PDIGREE Trial in Metastatic Untreated RCC

PDIGREE Trial in Metastatic Untreated RCC

obr

7 months
131 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Tian Zhang , MD, Assistant Professor of Medicine, Duke Cancer Institute, explains the design on the outcomes of the PDIGREE trial in metastatic, untreated renal cell carcinoma.
Up Next Autoplay